Noxopharm Ltd reveals new Sofra™ drug reduces inflammation

A new pre-clinical product candidate from Noxopharm Ltd (ASX:NOX, OTC:NOXOF)’s Sofra™ technology platform, known as SOF-XX, has shown to be effective...

Related Keywords

Australia ,Seoul ,Soult Ukpyolsi ,South Korea ,Gisela Mautner ,Michael Gantier ,Hudson Institute ,Noxopharm Ltd ,Melbourne Hudson Institute Of Medical Research ,International Congress On Systemic Lupus Erythematosus ,Medical Research ,International Congress ,Systemic Lupus Erythematosus ,Associate Professor Michael Gantier ,